Integrity Alliance’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Buy
114,028
+430
+0.4% +$11.4K 0.12% 148
2025
Q4
$2.83M Buy
113,598
+22,457
+25% +$566K 0.1% 166
2025
Q3
$2.32M Buy
91,141
+39,127
+75% +$966K 0.11% 154
2025
Q2
$1.26M Sell
52,014
-72,813
-58% -$1.7M 0.07% 193
2025
Q1
$3.16M Buy
124,827
+73,788
+145% +$1.93M 0.13% 136
2024
Q4
$1.35M Buy
+51,039
New +$1.38M 0.15% 88

Other funds holding PFE

Integrity Alliance's PFE Position: Q1 2026 in Review

Integrity Alliance increased its Pfizer (PFE) stake by 0.38% in Q1 2026, buying an estimated $11.4K and bringing the position to 114,028 shares worth $3.2M. The position accounts for 0.12% of the portfolio, ranked #148.

Integrity Alliance first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Integrity Alliance held 114,028 shares of Pfizer worth $3.2M as of Q1 2026.
  • Integrity Alliance bought 430 Pfizer shares in Q1 2026, an estimated $11.4K.
  • Pfizer made up 0.12% of Integrity Alliance's portfolio in Q1 2026, its #148 holding.
  • Integrity Alliance first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.